This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Livent (LTHM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Livent's (LTHM) Q4 results are likely to reflect the benefits of higher realized pricing and strong lithium demand.
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
While demand slowdown in several end markets is likely to be a drag, Albemarle (ALB), Celanese (CE), Huntsman (HUN) and Westlake (WLK) are likely to have benefited from cost and pricing actions in Q4.
Albemarle (ALB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $279.34 in the latest trading session, marking a +0.91% move from the prior day.
DuPont de Nemours (DD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 12.66% and 0.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Bunge Limited (BG) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Bunge Limited's (BG) fourth-quarter results are likely to reflect favorable markets in the Refined and Specialty Oils and the Milling segments.
Is a Beat in the Offing for Linde (LIN) in Q4 Earnings?
by Zacks Equity Research
Higher industrial production in the December quarter is likely to have aided Linde's (LIN) Q4 earnings.
DuPont (DD) Warms Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from strong end-market demand and its pricing and productivity actions in the fourth quarter.
Albemarle (ALB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $285.90 in the latest trading session, marking a +1.58% move from the prior day.
Air Products (APD) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Air Products' (APD) Q1 performance is likely to have been driven by improved cost structures & productivity actions amid headwinds from high power costs, softer volumes & adverse currency movements.
WestRock (WRK) Gears Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
WestRock's (WRK) Q1 results are likely to reflect the recent weakness in packaging demand, lower shipping days and the impacts of maintenance downtime.
What's in Store for Southern Copper (SCCO) in Q4 Earnings?
by Zacks Equity Research
Southern Copper's (SCCO) fourth-quarter 2022 results are likely to reflect the impacts of lower production and higher operating costs, as well as weak copper and silver prices.
Albemarle (ALB) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $264.59 in the latest trading session, marking no change from the prior day.
Is Trending Stock Albemarle Corporation (ALB) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Implied Volatility Surging for Albemarle (ALB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Albemarle (ALB) stock based on the movements in the options market lately.
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $239.11, marking a -1.92% move from the previous day.
Why Albemarle (ALB) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How to Find Strong Basic Materials Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $242.23 in the latest trading session, marking a -0.4% move from the prior day.
Here's Why You Should Retain Albemarle (ALB) in Your Portfolio
by Zacks Equity Research
Albemarle (ALB) gains on strong demand and prices in its lithium unit and actions to boost its global lithium conversion capacity amid headwinds from cost inflation.
Is Most-Watched Stock Albemarle Corporation (ALB) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Albemarle (ALB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $221.64, moving +1.39% from the previous trading session.
Albemarle (ALB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $217.47, moving +1.6% from the previous trading session.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Albemarle (ALB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $226.96 in the latest trading session, marking a +0.43% move from the prior day.